CircPRKD3-loaded exosomes concomitantly elicit tumor growth inhibition and glioblastoma microenvironment remodeling via inhibiting STAT3 signaling
Neuro-Oncology · 2025
DOI: 10.1093/neuonc/noaf019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Xiaoming Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Key Laboratory of Brain Function and Diseases, Hefei, P.R. China. Hauptthemen laut MEDLINE: Exosomes, STAT3 Transcription Factor, Glioblastoma, RNA, Circular. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Anhui Province.
Abstract (Originalsprache)
Background
Glioblastoma stem cells and their exosomes (exos) are involved in shaping the immune microenvironment, which is important for tumor invasion and recurrence. However, studies involving GSC-derived exosomal circular RNAs (GDE-circRNAs) in regulating tumor microenvironment (TME) remain unknown. Here, we comprehensively evaluated the significance of a novel immune-related GDE-circRNA in the glioma microenvironment.
Methods
GDE-circPRKD3 was screened out through high-throughput sequencing and verified by RT-PCR, sanger sequencing, and RNase R assays. A series of in vitro and in vivo experiments were performed to investigate the function of GDE-circPRKD3. RNA-seq, RNA immunoprecipitation, multicolor flow cytometry, and western blotting were used to explore the regulation of GDE-circPRKD3 on STAT3 signaling-mediated TME remodeling.
Results
We have characterized a circRNA PRKD3 in GSC exosomes, and lower circPRKD3 expression predicts a worse prognosis for glioblastoma patients. Overexpression of GDE-circPRKD3 significantly impairs the biological competence of glioma and prolongs the survival of xenograft mice. GDE-circPRKD3 binds to HNRNPC in an m6A-dependent manner, accelerates mRNA decay of IL6ST, and inhibits downstream target STAT3. Notably, GDE-circPRKD3 promotes CXCL10 secretion by reprogramming tumor-associated macrophages, which in turn recruits CD8+ tumor-infiltrating lymphocytes against GBM. Moreover, brain-targeted lipid nanoparticle delivery of circPRKD3 combined with immune checkpoint blockade therapy achieves significant combinatorial benefits.
Conclusions
This study provides a novel mechanism by which GDE-circPRKD3 relies on STAT3 signaling to remodel immunosuppressive TME and offers a potential RNA immunotherapy strategy for GBM treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anhui Key Laboratory of Brain Function and Diseases, Hefei, P.R. China.
- Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P.R. China.
- Department of Chemistry, University of Science & Technology of China, Hefei, P.R. China.
- Anhui Provincial Clinical Research Center for Neurosurgical Disease, Hefei, P.R. China.
- Anhui Provincial Stereotactic Neurosurgical Institute, Hefei, P.R. China.
ORCID-Profile: Shanshan Hu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
Zitieren
APA
Zhang, X., Jiang, M., Niu, W., Xu, B., Zhang, C., Yang, M., Hu, S., & Niu, C. (2025). CircPRKD3-loaded exosomes concomitantly elicit tumor growth inhibition and glioblastoma microenvironment remodeling via inhibiting STAT3 signaling. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf019
Vancouver
Zhang X, Jiang M, Niu W, Xu B, Zhang C, Yang M, et al. CircPRKD3-loaded exosomes concomitantly elicit tumor growth inhibition and glioblastoma microenvironment remodeling via inhibiting STAT3 signaling. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf019
BibTeX
@article{Zhang2025,
author = {Zhang, Xiaoming and Jiang, Mengyuan and Niu, Wanxiang and Xu, Ben and Zhang, Ce and Yang, Minglong and Hu, Shanshan and Niu, Chaoshi},
title = {CircPRKD3-loaded exosomes concomitantly elicit tumor growth inhibition and glioblastoma microenvironment remodeling via inhibiting STAT3 signaling},
journal = {Neuro-Oncology},
year = {2025},
doi = {10.1093/neuonc/noaf019}
}
EUVIMED